USO DO CANABIDIOL PARA O CONTROLE DA DOR OROFACIAL CRÔNICA: REVISÃO DE LITERATURA
Resumo
Palavras-chave
Texto completo:
11Referências
Sadighparvar S, Al-Hamed FS, Sharif-Naeini R, Meloto CB. Preclinical orofacial pain assays and measures and chronic primary orofacial pain research: where we are and where we need to go. Front pain Res (Lausanne, Switzerland). 2023;4:1150749.
Rajaa SN, *, Daniel B. Carrb M, Cohenc, Nanna B. Finnerupd, e HF, , Stephen Gibsong FJK, Mogili JS, Ringkampj M, et al. Definição revisada de dor pela Associação Internacional para o Estudo da Dor: conceitos, desafios e compromissos. Phys Ther. 2020;100(12):2077–8.
Siqueira JTT. Dor Orofacial: Evolução e desafios à Odontologia. Dores Orofaciais Diagnóstico e Trat. 2012;1:17–37.
Aguiar DP, Souza CP de Q, Barbosa WJM, Santos-Júnior FFU, Oliveira AS de. Prevalence of chronic pain in Brazil: systematic review. Brazilian J Pain. 2021;4(3):257–67.
Merrill RL. Central mechanisms of orofacial pain. Dent Clin North Am. 2007 Jan;51(1):45–59, v.
Tambeli CH, Martins GA, Barbosa SL, Machado TT. Abordagem integrativa do uso terapêutico da cannabis nas dores orofaciais. Brazilian J Pain. 2023;6(s1):49–53.
Beneng K, Renton T, Yilmaz Z, Yiangou Y, Anand P. Cannabinoid receptor CB1-immunoreactive nerve fibres in painful and non-painful human tooth pulp. J Clin Neurosci Off J Neurosurg Soc Australas. 2010 Nov;17(11):1476–9.
Saito VM, Wotjak CT, Moreira FA. [Pharmacological exploitation of the endocannabinoid system: new perspectives for the treatment of depression and anxiety disorders?]. Rev Bras Psiquiatr [Internet]. 2010;32 Suppl 1:S7-14. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20512266
Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia [Internet]. 2018 Jan 25;38(1):1–211. Available from: http://journals.sagepub.com/doi/10.1177/0333102417738202
International Classification of Orofacial Pain, 1st edition (ICOP). Cephalalgia. 2020 Feb;40(2):129–221.
ALVES JEDO, SILVEIRA MD, VIEIRA EMP, VIDAL LW de M. Mecanismos Fisiopatológicos Da Nocicepção E Bases Da Analgesia Perioperatória Em Pequenos Animais. Acta Biomédica Bras. 2017;8(1):56.
Ananthan S, Benoliel R. Chronic orofacial pain. J Neural Transm. 2020 Apr;127(4):575–88.
ROSSI MA. Anatomia craniofacial aplicada à odontologia: abordagem fundamental e clínica. 2017.
Ferreira LA, Grossmann E, Januzzi E, de Paula MVQ, Carvalho ACP. Diagnosis of temporomandibular joint disorders: Indication of imaging exams. Braz J Otorhinolaryngol [Internet]. 2016;82(3):341–52. Available from: http://dx.doi.org/10.1016/j.bjorl.2015.06.010
Crincoli V, Anelli MG, Quercia E, Piancino MG, Di Comite M. Temporomandibular Disorders and Oral Features in Early Rheumatoid Arthritis Patients: An Observational Study. Int J Med Sci. 2019;16(2):253–63.
Costa Dutra L da, Guerra-Seabra EJ, Souza da Fonseca Dutra GR, Silva AP da, Lucena EE de S. [Dental condiction of patients with temporomandibular dysfunction]. Rev Salud Publica (Bogota). 2019 May;21(3):376–80.
Neville B. Patologia Oral e Maxilofacial [Internet]. Elsevier Brasil; 2011. Available from: https://books.google.com.br/books?id=TCoqQ5jnQ7wC
Maarbjerg S, Di Stefano G, Bendtsen L, Cruccu G. Trigeminal neuralgia - diagnosis and treatment. Cephalalgia. 2017 Jun;37(7):648–57.
Bendtsen L, Zakrzewska JM, Heinskou TB, Hodaie M, Leal PRL, Nurmikko T, et al. Advances in diagnosis, classification, pathophysiology, and management of trigeminal neuralgia. Lancet Neurol. 2020 Sep;19(9):784–96.
Bicca C, Ramos F, Campos V, Assis F, Pulchinelli Jr A. Abuso e Dependência dos Opioides e Opiáceos. Assoc Bras Psiquiatr. 2012;1–30.
Nascimento DCH, Sakata RK. Dependência de opioide em pacientes com dor crônica. Soc Bras para o Estud da Dor. 2011;12(2):160–5.
Yu C, Abbott P V. An overview of the dental pulp: its functions and responses to injury. Aust Dent J. 2007 Mar;52(1 Suppl):S4-16.
Fonseca B, Costa M, Almada M, Soares A, Correia-da-Silva G, Teixeira N. O Sistema Endocanabinóide – uma perspetiva terapêutica. Acta Farm Port. 2013;2(2):37–44.
Martínez-Pinilla E, Varani K, Reyes-Resina I, Angelats E, Vincenzi F, Ferreiro-Vera C, et al. Binding and Signaling Studies Disclose a Potential Allosteric Site for Cannabidiol in Cannabinoid CB(2) Receptors. Front Pharmacol. 2017;8:744.
Bisht K, Okojie KA, Sharma K, Lentferink DH, Sun YY, Chen HR, et al. Capillary-associated microglia regulate vascular structure and function through PANX1-P2RY12 coupling in mice. Nat Commun [Internet]. 2021;12(1). Available from: http://dx.doi.org/10.1038/s41467-021-25590-8
Lima IV de A, Bellozi PMQ, Batista EM, Vilela LR, Brandão IL, Ribeiro FM, et al. Cannabidiol anticonvulsant effect is mediated by the PI3Kγ pathway. Neuropharmacology. 2020 Oct;176:108156.
Lucas CJ, Galettis P, Schneider J. The pharmacokinetics and the pharmacodynamics of cannabinoids. Br J Clin Pharmacol. 2018 Nov;84(11):2477–82.
Paudel KS, Hammell DC, Agu RU, Valiveti S, Stinchcomb AL. Cannabidiol bioavailability after nasal and transdermal application: effect of permeation enhancers. Drug Dev Ind Pharm. 2010 Sep;36(9):1088–97.
Paudel KS, Milewski M, Swadley CL, Brogden NK, Ghosh P, Stinchcomb AL. Challenges and opportunities in dermal/transdermal delivery. Ther Deliv. 2010;1(1):109–31.
Bilbao A, Spanagel R. Medical cannabinoids: a pharmacology-based systematic review and meta-analysis for all relevant medical indications. BMC Med [Internet]. 2022;20(1):1–29. Available from: https://doi.org/10.1186/s12916-022-02459-1
Matias GFS, Lima MAC, Costa TA, Faria MS, Nascimento IBO, Debbo A. Uso de Cannabis para tratamento da dor crônica: uma revisão sistemática. Res Soc Dev. 2022;11(3):e25411326586.
Programa Institucional de Política de Drogas DH e SM da F. Estado atual das evidências sobre usos terapêuticos da. 2023.
Bergamaschi MM, Queiroz RHC, Zuardi AW, Crippa JAS. Safety and side effects of cannabidiol, a Cannabis sativa constituent. Curr Drug Saf. 2011 Sep;6(4):237–49.
Reis LC dos, Luz DU, Silva ABA da, Fernandes FR, Assis I. Desvendando O Uso Da Toxina Botulínica Na Estética E Em Enfermidades. Rev Saúde em Foco. 2020;12:413–37.
Lowe H, Toyang N, Steele B, Bryant J, Ngwa W, Nedamat K. The Current and Potential Application of Medicinal Cannabis Products in Dentistry. Dent J. 2021 Sep;9(9).
Nitecka-Buchta A, Nowak-Wachol A, Wachol K, Walczyńska-Dragon K, Olczyk P, Batoryna O, et al. Myorelaxant effect of transdermal cannabidiol application in patients with TMD: A randomized, double-blind trial. J Clin Med. 2019;8(11).
Überall MA. A review of scientific evidence for THC:CBD oromucosal spray (nabiximols) in the management of chronic pain. J Pain Res. 2020;13:399–410.
Blasco-Benito S, Seijo-Vila M, Caro-Villalobos M, Tundidor I, Andradas C, García-Taboada E, et al. Appraising the “entourage effect”: Antitumor action of a pure cannabinoid versus a botanical drug preparation in preclinical models of breast cancer. Biochem Pharmacol. 2018 Nov;157:285–93.
Pamplona FA. Quais são e pra que servem os medicamentos à base de Cannabis? Rev da Biol. 2014;13(1):28–35.
Carneiro H. Proibição da Maconha: racismo e violência no Brasil. Cah des Amériques Lat [Internet]. 2019 Dec 30;(92):135–52. Available from: http://journals.openedition.org/cal/10049
Karla Soares M. IGNORÂNCIA E POLÍTICAS PÚBLICAS: REFLEXÕES SOBRE A REGULAÇÃO DE CANNABIS PARA USO MEDICINAL NO BRASIL. Livros [Internet]. 2022 Apr 12;(Políticas públicas):673–95. Available from: https://repositorio.ipea.gov.br/bitstream/11058/11389/1/politica_publica_Cannabis_cap21.pdf
Apontamentos
- Não há apontamentos.
